MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avadel Pharmaceuticals plc - Ordinary Share (NQ:AVDL)

21.59 +0.01 (+0.05%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 299,066
Open 21.57
Bid (Size) 21.58 (1,200)
Ask (Size) 21.59 (1,900)
Prev. Close 21.58
Today's Range 21.51 - 21.60
52wk Range 6.380 - 23.57
Shares Outstanding 96,116,323
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halper Sadeh LLC Encourages AVDL, CMA, KVUE Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Avadel Pharmaceuticals (NASDAQ:AVDL) Combines Strong Growth Momentum with Favorable Technical Setup ↗
Avadel Pharmaceuticals (AVDL) combines strong revenue growth, a shift to profitability, and a solid technical uptrend, offering a potential entry for momentum investors. 
Via Chartmill

Performance

YTD
+96.3%
+96.3%
1 Month
+0.5%
+0.5%
3 Month
+41.0%
+41.0%
6 Month
+144.0%
+144.0%
1 Year
+104.9%
+104.9%

More News

Read More
News headline image
Halper Sadeh LLC Encourages GIFI, AVDL, JAMF, CDE Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge ↗
Via Stocktwits
News headline image
Halper Sadeh LLC Encourages HFWA, FITB, AVDL, BRNS Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Top 2 Health Care Stocks That May Fall Off A Cliff This Month ↗
Via Benzinga
News headline image
Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal ↗
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
Avadel Surges 20% On Lundbeck's Surprise Alkermes-Topping Bid ↗
Via Investor's Business Daily
News headline image
Halper Sadeh LLC Encourages TRUE, AVDL, GES Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes ↗
Via Stocktwits
News headline image
Avadel Pharmaceuticals (NASDAQ:AVDL) Meets Minervini Trend Template with High-Growth Momentum ↗
Via Chartmill
News headline image
Deal Dispatch: From Four Roses Bourbon To Quantum Stakes, Here Are This Week's Sector Shake Ups ↗
Via Benzinga
Topics Government
News headline image
HALPER SADEH LLC ENCOURAGES FSFG, AVDL, MBCN SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Tesla To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Via Benzinga
News headline image
This Winnebago Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
Via Benzinga
News headline image
Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz ↗
Via Benzinga
News headline image
Beyond The Numbers: 5 Analysts Discuss Avadel Pharmaceuticals Stock ↗
Via Benzinga
News headline image
Avadel Pharmaceuticals Soars as Alkermes Announces $2.1 Billion Acquisition
Via MarketMinute
Topics Intellectual Property
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives. ↗
Via Investor's Business Daily
News headline image
Avadel Stock Rises After Acquisition Offer By Alkermes ↗
Via Stocktwits

Frequently Asked Questions

Is Avadel Pharmaceuticals plc - Ordinary Share publicly traded?
Yes, Avadel Pharmaceuticals plc - Ordinary Share is publicly traded.
What exchange does Avadel Pharmaceuticals plc - Ordinary Share trade on?
Avadel Pharmaceuticals plc - Ordinary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Avadel Pharmaceuticals plc - Ordinary Share?
The ticker symbol for Avadel Pharmaceuticals plc - Ordinary Share is AVDL on the Nasdaq Stock Market
What is the current price of Avadel Pharmaceuticals plc - Ordinary Share?
The current price of Avadel Pharmaceuticals plc - Ordinary Share is 21.59
When was Avadel Pharmaceuticals plc - Ordinary Share last traded?
The last trade of Avadel Pharmaceuticals plc - Ordinary Share was at 12/26/25 04:00 PM ET
What is the market capitalization of Avadel Pharmaceuticals plc - Ordinary Share?
The market capitalization of Avadel Pharmaceuticals plc - Ordinary Share is 2.08B
How many shares of Avadel Pharmaceuticals plc - Ordinary Share are outstanding?
Avadel Pharmaceuticals plc - Ordinary Share has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story